Purpose: There is marked variability in treatment fields for glioblastoma. We performed a retrospective study comparing outcomes of patients treated according to MD Anderson Cancer Center (MDACC) or Radiation Therapy Oncology Group (RTOG) guidelines and identified differences in treatment-related toxicity.
Methods And Materials: Adult patients with glioblastoma treated with surgery and adjuvant radiation treatment were included in this study.